PRODUCT

PT-141 (10 mg) + Melanotan II (10 mg) Stack

No short description available.

Quickstart Highlights

PT-141 (bremelanotide) and Melanotan II are cyclic melanocortin receptor agonists with distinct but related applications. PT-141 is FDA-approved for hypoactive sexual desire disorder and is used on-demand, while Melanotan II has been studied for its effects on skin pigmentation and sexual function with daily dosing protocols. This educational guide covers reconstitution, dosing, and administration for both peptides.

Reconstitute each: Add 3.0 mL bacteriostatic water → ~3.33 mg/mL concentration.
PT-141 dose: 750–1750 mcg on-demand (≥45 min before activity); max 1 dose per 24 h.
Melanotan II dose: 250–1000 mcg once daily with gradual titration.
Easy measuring: At 3.33 mg/mL, 1 unit = 0.01 mL ≈ 33.3 mcg on a U-100 insulin syringe.
Storage: Lyophilized: freeze at −20 °C (−4 °F); reconstituted: refrigerate at 2–8 °C and use within ~1 week.

Reconstitution

Draw 3.0 mL bacteriostatic water with a sterile syringe.
Inject slowly down the vial wall; avoid foaming or direct impact on the powder.
Gently swirl or roll until fully dissolved (do not shake).
Label with date, peptide name, and concentration; refrigerate at 2–8 °C (35.6–46.4 °F) , protected from light.
Label with date, peptide name, and concentration; refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Protocol Overview

PT-141:On-demand subcutaneous use for sexual function; typical dose 1.75 mg (1750 mcg) administered ≥45 min before activity[1].
Melanotan II:Daily subcutaneous injections during loading phase (4–8 weeks), then 2–3× weekly maintenance for pigmentation and related effects[5].
Reconstitution:3.0 mL per 10 mg vial (~3.33 mg/mL) for both peptides.
Storage:Lyophilized frozen at −20 °C (−4 °F); reconstituted refrigerated at 2–8 °C (35.6–46.4 °F).

Dosage Protocols

Timing:PT-141 at least 45 min before activity; Melanotan II at any consistent time daily.

Storage Instructions

Lyophilized:Store at −20 °C (−4 °F) in dry, dark conditions; PT-141 shows short-term room-temperature stability (~3 weeks) if needed[7].
Reconstituted:Refrigerate at 2–8 °C (35.6–46.4 °F); use within approximately 1 week for optimal potency. Avoid repeated freeze–thaw cycles;

Important Notes

Practical considerations for consistency and safety.

Use new sterile insulin syringes for each injection; dispose in a sharps container.
Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.
Inject slowly; wait a few seconds before withdrawing the needle.
Document each dose, time, and injection site to maintain consistency.
PT-141: Do not exceed 8 doses per month or 1 dose per 24 hours[1].
Melanotan II: UV exposure (sun or controlled tanning) during use may enhance pigmentation effects; appropriate sun protection is advised[6].

Lifestyle Factors

Maintain adequate hydration, especially given potential nausea with initial doses.
For Melanotan II users seeking pigmentation: controlled, gradual UV exposure may enhance results; always use appropriate sun protection to minimize skin damage risk.
Prioritize sleep and stress management; both influence hormonal balance and overall response.
Monitor for any new or changing skin lesions and consult a healthcare provider if noted.

Injection Technique

Clean the vial stopper with an alcohol swab; allow to dry completely.
Clean the injection site (abdomen or thigh) with an alcohol swab for at least 30 seconds; allow to dry[8].
Pinch a fold of skin; insert the needle at 45–90° depending on subcutaneous tissue depth[9][10].
Aspiration is not required for subcutaneous injections; inject slowly and steadily[8].
Release the skin fold, withdraw the needle, and apply gentle pressure if needed.
Rotate sites systematically (abdomen, thighs, upper arms) to prevent lipohypertrophy or irritation[9].

Benefits and Side Effects

Benefits

Observations from clinical and research literature.

PT-141 (10 mg) + Melanotan II (10 mg) Stack

Resources

Categories

Company